Immunopathogenesis of the multiple sclerosis lesion (original) (raw)

• Cannella B, Raine CS: The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 1995, 37:424–435.
  Article PubMed CAS Google Scholar
• Bo L, Mork S, Kong PA, et al.: Detection of MHC class IIantigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol 1994, 51:135–146.
  Article PubMed CAS Google Scholar
• Babbe H, Roers A, Waisman A, et al.: Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 2000, 192:393–404. T-cell receptor repertoire of CD4+ and CD8+ cells infiltrating actively demyelinating multiple sclerosis (MS) lesions was determined at the single cell level. Expanded CD8+ T-cell clones were predominantly identified in MS lesions.
  Article PubMed CAS Google Scholar
• Cross AH, Cannella B, Brosnan CF, et al.: Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab Invest 1990, 63:162–170.
  PubMed CAS Google Scholar
• Lucchinetti C, Bruck W, Parisi J, et al.: A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 1999, 122:2279–2295.
  Article PubMed Google Scholar
• Scolding N, Franklin R, Stevens S, et al.: Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain 1998, 121:2221–2228.
  Article PubMed Google Scholar
• Trapp BD, Peterson J, Ransohoff RM, et al.: Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998, 338:278–285.
  Article PubMed CAS Google Scholar
• Ferguson B, Matyszak MK, Esiri MM, et al.: Axonal damage in acute multiple sclerosis lesions. Brain 1997, 120:393–399.
  Article PubMed Google Scholar
• Bielekova B, Goodwin B, Richert N, et al.: Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat Med 2000, 6:1167–1175. In this clinical trial, the treatment with altered peptide ligand adversely increased the frequency of T cells cross-reactive with myelin basic protein epitope 83–99.
  Article PubMed CAS Google Scholar
• Scholz C, Patton KT, Anderson DE, et al.: Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. J Immunol 1998, 160:1532–1538.
  PubMed CAS Google Scholar
• Lovett-Racke AE, Trotter JL, Lauber J, et al.: Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. J Clin Invest 1998, 101:725–730.
  Article PubMed CAS Google Scholar
• Schirmer M, Vallejo AN, Weyand CM, et al.: Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28-T cells from rheumatoid arthritis patients. J Immunol 1998, 161:1018–1025.
  PubMed CAS Google Scholar
• Tivol EA, Borriello F, Schweitzer AN, et al.: Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995, 3:541–547.
  Article PubMed CAS Google Scholar
• Bachmaier K, Krawczyk C, Kozieradzki I, et al.: Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 2000, 403:211–216.
  Article PubMed CAS Google Scholar
• Thornton AM, Shevach EM: CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998, 188:287–296.
  Article PubMed CAS Google Scholar
• Read S, Malmstrom V, Powrie F: Cytotoxic T lymphocyteassociated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000, 192:295–302.
  Article PubMed CAS Google Scholar
• Hemmer B, Gran B, Zhao Y, et al.: Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat Med 1999, 5:1375–1382. In a patient with chronic neuroborreliosis, the authors identified a range of T-cell ligands from Borrelia burgdorferi and self-tissues.
  Article PubMed CAS Google Scholar
• Challoner PB, Smith KT, Parker JD, et al.: Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 1995, 92:7440–7444.
  Article PubMed CAS Google Scholar
• Sriram S, Stratton CW, Yao S, et al.: Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol 1999, 46:6–14.
  Article PubMed CAS Google Scholar
• Hemmer B, Vergelli M, Gran B, et al.: Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology. J Immunol 1998, 160:3631–3666.
  PubMed CAS Google Scholar
• Evans CF, Horwitz MS, Hobbs MV, et al.: Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease. J Exp Med 1996, 184:2371–2384.
  Article PubMed CAS Google Scholar
• Horwitz MS, Bradley LM, Harbertson J, et al.: Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 1998, 4:781–785.
  Article PubMed CAS Google Scholar
• Carrithers MD, Visintin I, Kang SJ, et al.: Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment. Brain 2000, 123:1092–1101.
  Article PubMed Google Scholar
• Hickey WF, Hsu BL, Kimura H: T-lymphocyte entry into the central nervous system. J Neurosci Res 1991, 28:254–260.
  Article PubMed CAS Google Scholar
• Brabb T, von Dassow P, Ordonez N, et al.: In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity. J Exp Med 2000, 192:871–880.
  Article PubMed CAS Google Scholar
• Krakowski ML, Owens T: Naive T lymphocytes traffic to inflamed central nervous system, but require antigen recognition for activation. Eur J Immunol 2000, 30:1002–1009.
  Article PubMed CAS Google Scholar
• Sallusto F, Lenig D, Forster R, et al.: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708–712.
  Article PubMed CAS Google Scholar
• Strunk T, Bubel S, Mascher B, et al.: Increased numbers of CCR5+ interferon-gamma- and tumor necrosis factoralpha-secreting T lymphocytes in multiple sclerosis patients. Ann Neurol 2000, 47:269–273.
  Article PubMed CAS Google Scholar
• Lucchinetti C, Bruck W, Parisi J, et al.: Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000, 47:707–717. A pathologic study on a large number of actively demyelinating lesions indicates a very heterogenous nature of multiple sclerosis lesions.
  Article PubMed CAS Google Scholar
• Genain CP, Cannella B, Hauser SL, et al.: Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med 1999, 5:170–175.
  Article PubMed CAS Google Scholar
• Wolswijk G: Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. Brain 2000, 123:105–515.
  Article PubMed Google Scholar
• Yao DL, Liu X, Hudson LD, et al.: Insulin-like growth factor-I given subcutaneously reduces clinical deficits, decreases lesion severity and upregulates synthesis of myelin proteins in experimental autoimmune encephalomyelitis. Life Sci 1996, 58:1301–1306.
  Article PubMed CAS Google Scholar
• McDonald JW, Liu XZ, Qu Y, et al.: Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 1999, 5:1410–1412.
  Article PubMed CAS Google Scholar
• Bitsch A, Schuchardt J, Bunkowski S, et al.: Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 2000, 123:1174–1183.
  Article PubMed Google Scholar
• Smith ME, Stone LA, Albert PS, et al.: Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol 1993, 33:480–489.
  Article PubMed CAS Google Scholar
• O’Riordan JI, Thompson AJ, Kingsley DP, et al.: The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain 1998, 121:495–503.
  Article PubMed Google Scholar
• Filippi M, Iannucci G, Tortorella C, et al.: Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology 1999, 52:588–594.
  PubMed CAS Google Scholar
• Brex PA, O’Riordan JI, Miszkiel KA, et al.: Multisequence MRI in clinically isolated syndromes and the early development of MS. Neurology 1999, 53:1184–1190.
  PubMed CAS Google Scholar
• Lee MA, Smith S, Palace J, et al.: Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis? Brain 1999, 122:1261–1270.
  Article PubMed Google Scholar
• Filippi M, Yousry T, Horsfield MA, et al.: A high-resolution three-dimensional T1-weighted gradient echo sequence improves the detection of disease activity in multiple sclerosis. Ann Neurol 1996, 40:901–907.
  Article PubMed CAS Google Scholar
• Filippi M, Rocca MA, Martino G, et al.: Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998, 43:809–814.
  Article PubMed CAS Google Scholar
• Stevenson VL, Leary SM, Losseff NA, et al.: Spinal cord atrophy and disability in MS: a longitudinal study. Neurology 1998, 51:234–238.
  PubMed CAS Google Scholar
• Werring DJ, Brassat D, Droogan AG, et al.: The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. Brain 2000, 123:1667–1676.
  Article PubMed Google Scholar
• De Stefano N, Narayanan S, Matthews PM, et al.: In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. Brain 1999, 122:1933–1939.
  Article PubMed Google Scholar
• Sarchielli P, Presciutti O, Pelliccioli GP, et al.: Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients. Brain 1999, 122:513–521.
  Article PubMed Google Scholar
• Jacobs LD, Beck RW, Simon JH, et al.: Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 2000, 343:898–904.
  Article PubMed CAS Google Scholar
• Truyen L, van Waesberghe JH, van Walderveen MA, et al.: Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996, 47:1469–1476.
  PubMed CAS Google Scholar
• Fox NC, Jenkins R, Leary SM, et al.: Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI. Neurology 2000, 54:807–812.
  PubMed CAS Google Scholar